Omkara Dance Festival & Parivartan-Generational Change in Dance Seminar

Manasa-Art Without Frontier premieres a unique dance festival bringing 2 dance troupes of Padmashri & Sangeet Natak Akademi Awardees from Odisha and Jharkhand, never seen in Delhi before. Conceived and curated by Guru Sharon Lowen on Friday, May 31st, 2024 and Saturday, June 1st, 2024 at India International Centre, New Delhi. Free Entry.

Ranjana Gauhar and dancers

Seraikella Chhau by ‘Trinetra‘ Chhau Dance Centre, Seraikella, founded by Late Guru Pt. Gopal Dubey, (Padmashree & SNA Awardee) and Odissi by Guru Kelucharan Mohapatra’s senior disciple, Guru Kumkum Mohanty (Padmashree & SNA Awardee) and her disciples. Additionally, Odissi performances by Guru Sharon Lowen’s Manasa-Art Without Frontiers dance troupe and that of Guru Ranjana Gauhar (Padmashree & SNA Awardee).

Performances from 6pm to 8:30pm at Deshmukh Auditorium, India International Centre, New Delhi.

On Friday, May 31st, 2024 :

– Seraikella Chhau by ‘Trinetra’ Chhau Dance Centre, Seraikella.

– Odissi by Guru Ranjana Gauhar (Padmashree, Ehsaas Awardee & SNA Awardee) and her disciples.

On Saturday, June 1st, 2024 :

– Odissi by Guru Kumkum Mohanty (Padmashree & SNA Awardee) and her disciples

– Odissi by Manasa-Art Without Frontiers, disciples of Guru Sharon Lowen, Ehsaas Awardee.

Parivartan-Generational Change in Dance Seminar on Saturday, June 1st, 2024 from 10am to 1pm at IIC Annexe Lecture Room India International Centre, New Delhi

– Smt. Kumkum Mohanty, the legendary senior most disciple of Padmabhushan Guru Kelucharan Mohapatra – personal knowledge of Odissi over the past 70 years

– Sunil Dubey, Director of Padmashri & SNA awardee, Gopal Dubey’s Trinetra Dance Centre, Seraikella.

– Navtej Johar, is an SNA awardee Bharatnatyam exponent & choreographer trained at Kalakshetra and NY University Performance Studies, current faculty at Ashoka University.

– Moderator, Guru Sharon Lowen

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

  • NMDC Hyderabad Marathon becomes India’s First Marathon to earn World Athletics’ Silver Sustainability Award

       From Boston to Berlin, Rome to Hyderabad, India’s Marathon earns place among World’s most Sustainable Athletics events   Hyderabad,…

    Read More

  • Government, corporates and global foundations join hands on PRAGATI to empower 20,000 agri-entrepreneurs

    Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan recently launched PRAGATI, a nationwide initiative to build 20,000 agri-entrepreneurs and…

    Read More

  • Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia

    Milan, Italy, July 08 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder. The findings, published in the Journal of Hepatology, show that a single systemic administration of a lentiviral vector encoding the MMUT gene led to sustained improvements in disease features in a validated mouse model of MMA, with effects lasting for the average lifespan of laboratory mice. Since the mice were treated when young, the study supports the durability of the gene therapy through postnatal growth and maturation of the liver. MMA is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme that plays a critical role in the body’s metabolism of food. Its absence results in the accumulation of toxic metabolites that lead to recurrent metabolic crises, growth failure, neurological impairment, and multi-organ damage. In the study, researchers also treated mice with a dose containing an optimized MMUT transgene, thereby improving therapeutic efficacy. In the same mouse model of MMA, this…

    Read More